| # | Title | Journal | Year | Citations |
|---|
| 1 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | PLoS Medicine | 2009 | 50,671 |
| 2 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | BMJ: British Medical Journal | 2009 | 36,486 |
| 3 | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | BMJ: British Medical Journal | 2011 | 23,287 |
| 4 | The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration | PLoS Medicine | 2009 | 13,772 |
| 5 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | BMJ: British Medical Journal | 2009 | 13,452 |
| 6 | RoB 2: a revised tool for assessing risk of bias in randomised trials | BMJ: British Medical Journal | 2019 | 10,984 |
| 7 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement | Journal of Clinical Epidemiology | 2009 | 9,774 |
| 8 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Lancet, The | 2007 | 9,433 |
| 9 | Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement | International Journal of Surgery | 2010 | 8,663 |
| 10 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Journal of Clinical Epidemiology | 2009 | 8,425 |
| 11 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Journal of Clinical Epidemiology | 2008 | 7,988 |
| 12 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies | PLoS Medicine | 2007 | 7,961 |
| 13 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials | BMJ: British Medical Journal | 2010 | 5,910 |
| 14 | Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide | BMJ, The | 2014 | 5,661 |
| 15 | Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research | PLoS Biology | 2010 | 5,621 |
| 16 | CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials | BMJ: British Medical Journal | 2010 | 5,319 |
| 17 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials | BMC Medicine | 2010 | 4,939 |
| 18 | Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies | BMJ: British Medical Journal | 2007 | 4,798 |
| 19 | Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials | BMJ: British Medical Journal | 2011 | 4,743 |
| 20 | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials | BMJ, The | 2013 | 3,435 |
| 21 | Animal research: Reporting in vivo experiments: The ARRIVE guidelines | British Journal of Pharmacology | 2010 | 3,150 |
| 22 | Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research | Journal of Pharmacology and Pharmacotherapeutics | 2010 | 2,743 |
| 23 | Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal | BMJ, The | 2020 | 2,134 |
| 24 | STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies | BMJ, The | 2015 | 1,914 |
| 25 | Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement | BMJ, The | 2015 | 1,842 |
| 26 | Consort 2010 statement: extension to cluster randomised trials | BMJ, The | 2012 | 1,840 |
| 27 | Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations | European Journal of Epidemiology | 2016 | 1,761 |
| 28 | Dichotomizing continuous predictors in multiple regression: a bad idea | Statistics in Medicine | 2006 | 1,711 |
| 29 | CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials | International Journal of Surgery | 2012 | 1,546 |
| 30 | CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials | Journal of Clinical Epidemiology | 2010 | 1,500 |
| 31 | International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project | Lancet, The | 2014 | 1,480 |
| 32 | No surgical innovation without evaluation: the IDEAL recommendations | Lancet, The | 2009 | 1,450 |
| 33 | Improving the reporting of pragmatic trials: an extension of the CONSORT statement | BMJ: British Medical Journal | 2008 | 1,327 |
| 34 | STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration | BMJ Open | 2016 | 1,324 |
| 35 | Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement | BMC Medicine | 2015 | 1,273 |
| 36 | Developing core outcome sets for clinical trials: issues to consider | Trials | 2012 | 1,226 |
| 37 | The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies* | Bulletin of the World Health Organization | 2007 | 1,159 |
| 38 | Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias | PLoS ONE | 2008 | 1,142 |
| 39 | CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials | PLoS Medicine | 2010 | 1,135 |
| 40 | The COMET Handbook: version 1.0 | Trials | 2017 | 1,128 |
| 41 | Prognosis and prognostic research: validating a prognostic model | BMJ: British Medical Journal | 2009 | 1,090 |
| 42 | PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies | Annals of Internal Medicine | 2019 | 1,066 |
| 43 | Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist | PLoS Medicine | 2014 | 1,036 |
| 44 | A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers | Journal of Clinical Epidemiology | 2009 | 1,013 |
| 45 | Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research | PLoS Medicine | 2013 | 1,006 |
| 46 | A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models | Journal of Clinical Epidemiology | 2019 | 992 |
| 47 | Reducing waste from incomplete or unusable reports of biomedical research | Lancet, The | 2014 | 982 |
| 48 | Prognosis and prognostic research: what, why, and how? | BMJ: British Medical Journal | 2009 | 952 |
| 49 | Prognosis and prognostic research: Developing a prognostic model | BMJ: British Medical Journal | 2009 | 906 |
| 50 | Guidance for Developers of Health Research Reporting Guidelines | PLoS Medicine | 2010 | 905 |
